-
Posted by
Two Blokes April 24, 2025 -
Filed in
Stock
-
11 views
Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or obesity and type 2 diabetes.
